Johanna Erber

1.0k total citations
30 papers, 317 citations indexed

About

Johanna Erber is a scholar working on Infectious Diseases, Neurology and Molecular Biology. According to data from OpenAlex, Johanna Erber has authored 30 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 6 papers in Neurology and 5 papers in Molecular Biology. Recurrent topics in Johanna Erber's work include COVID-19 Clinical Research Studies (10 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Long-Term Effects of COVID-19 (6 papers). Johanna Erber is often cited by papers focused on COVID-19 Clinical Research Studies (10 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Long-Term Effects of COVID-19 (6 papers). Johanna Erber collaborates with scholars based in Germany, Austria and United States. Johanna Erber's co-authors include Rainer Kaiser, Raphael Escaig, Leo Nicolai, Roland M. Schmid, Jochen Schneider, Ulrike Protzer, Tobias Lahmer, Christoph D. Spinner, Sebastian Rasch and Dieter Hoffmann and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Johanna Erber

28 papers receiving 315 citations

Peers

Countries citing papers authored by Johanna Erber

Since Specialization

Citations

This map shows the geographic impact of Johanna Erber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johanna Erber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johanna Erber more than expected).

Fields of papers citing papers by Johanna Erber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johanna Erber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johanna Erber. The network helps show where Johanna Erber may publish in the future.

Co-authorship network of co-authors of Johanna Erber

This figure shows the co-authorship network connecting the top 25 collaborators of Johanna Erber. A scholar is included among the top collaborators of Johanna Erber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johanna Erber. Johanna Erber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Electronic data capture in resource-limited settings using the lightweight clinical data acquisition and recording system 2024 ·Scientific Reports ·Jakob Vielhauer, Ujjwal Mukund Mahajan, Kristina Adorjan, (unknown), Bettina Oehrle, Georg Beyer, (unknown), (unknown), (unknown), (unknown), Johanna Erber, (unknown), Christian Schulz, (unknown), Ludwig Christian Hinske, Julia Mayerle, Hans Stubbe	0
2	Postmortem Minimally Invasive Autopsy in Critically Ill COVID-19 Patients at the Bedside: A Proof-of-Concept Study at the ICU 2024 ·Diagnostics ·Tobias Lahmer, Gregor Weirich, Štefan Porubský, Sebastian Rasch, (unknown), (unknown), Peter J. Schüffler, Johanna Erber, (unknown), Claire Delbridge, (unknown), Samuel Jeske, (unknown), Adam Chaker, Markus Heim, Uwe Heemann, Roland M. Schmid, Wilko Weichert, Konrad Stock, Julia Slotta‐Huspenina	1
3	Clinical and immunological outcomes of SARS-CoV-2-infected vaccine responders, vaccine non-responders, and unvaccinated patients evaluated for neutralizing monoclonal antibody treatment at a single German tertiary care center: a retrospective cohort study with prospective follow-up 2024 ·Infection ·(unknown), Jochen Schneider, Christoph D. Spinner, Roman Iakoubov, Florian Voit, (unknown), Johanna Erber, Kathrin Rothe, Achim Berthele, (unknown), (unknown), Lutz Renders, Anja Willmann, (unknown), Emanuel Vogel, Catharina Christa, Dieter Hoffmann, Ulrike Protzer, Samuel Jeske	3
4	Is doxycycline post-exposure prophylaxis being utilised in Germany? Insights from an online survey among German men who have sex with men 2024 ·Infection ·(unknown), Christoph Boesecke, Axel Baumgarten, (unknown), (unknown), Christian Hoffmann, Franz Audebert, Sebastian Noé, Johanna Erber, Marcel Lee, (unknown), Jochen Schneider, Christoph D. Spinner, Florian Voit	5
5	Platelet aggregates detected using quantitative phase imaging associate with COVID-19 severity 2023 ·SHILAP Revista de lepidopterología ·(unknown), Johanna Erber, (unknown), (unknown), (unknown), (unknown), (unknown), Martin Schlegel, Bernhard Haller, Tobias Lahmer, Klaus Diepold, Sebastian Rasch, Oliver Hayden	13
6	Validation of the SACOV-19 score for identifying patients at risk of complicated or more severe COVID-19: a prospective study 2023 ·Infection ·Ujjwal Mukund Mahajan, Johanna Erber, (unknown), Florian Voit, Jakob Vielhauer, (unknown), (unknown), Najib Ben Khaled, (unknown), (unknown), Matthias Klein, Carolin Jakob, Marcus Oswald, Rainer König, Christian Schulz, Julia Mayerle, Hans Stubbe	1
7	Rapid point-of-care detection of SARS-CoV-2 infection in exhaled breath using ion mobility spectrometry: a pilot study 2023 ·European journal of medical research ·Florian Voit, Johanna Erber, Martin Feuerherd, (unknown), Norman Bitterlich, (unknown), (unknown), J. Lieb, Ulrike Protzer, Jochen Schneider, Fabian Geisler, Rajan Somasundaram, Roland M. Schmid, Wolfgang Bauer, Christoph D. Spinner	1
8	Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19 2022 ·Gut Microbes ·David Schult, Sandra Reitmeier, (unknown), Tobias Lahmer, Moritz Middelhoff, Johanna Erber, Jochen Schneider, (unknown), (unknown), Julia Horstmann, (unknown), Katja Steiger, Moritz Jesinghaus, Klaus‐Peter Janssen, Ulrike Protzer, Klaus Neuhaus, Roland M. Schmid, Dirk Haller, Michael Quante	59
9	CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients 2022 ·PLoS ONE ·(unknown), Victoria Kehl, Johanna Erber, (unknown), (unknown), (unknown), Kilian Schober, Philipp Schommers, Max Augustin, Claudia S. Crowell, Markus Gerhard, Christof Winter, Andreas Moosmann, Christoph D. Spinner, Ulrike Protzer, Dieter Hoffmann, Elvira D’Ippolito, Dirk H. Busch	20
10	Risk factors for Herpes simplex virus and Cytomegalovirus infections in critically-ill COVID-19 patients 2022 ·Multidisciplinary Respiratory Medicine ·Kristina Fuest, Johanna Erber, (unknown), Markus Heim, Dieter Hoffmann, Barbara Kapfer, (unknown), Bernhard Ulm, Roland M. Schmid, Sebastian Rasch, Tobias Lahmer	9
11	Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages 2022 ·Mucosal Immunology ·(unknown), Franziska Hartung, Fiona Henkel, Alessandro Quaranta, Johan Kolmert, Alina Priller, (unknown), (unknown), (unknown), (unknown), Sarah Yazici, (unknown), Johanna Erber, Ulrike Protzer, Paul Lingor, Percy A. Knolle, Adam Chaker, Carsten B. Schmidt‐Weber, Craig E. Wheelock, Julia Esser‐von Bieren	39
12	Best practice approaches to outpatient management of people living with Parkinson’s disease during the COVID-19 pandemic 2022 ·Journal of Neural Transmission ·(unknown), (unknown), Johanna Erber, Friedemann Gebhardt, Erica Westenberg, Andrea Sylvia Winkler, (unknown), Iris F. Chaberny, Paul Lingor	1
13	Neutrophil-Platelet Interactions as Novel Treatment Targets in Cardiovascular Disease 2022 ·Frontiers in Cardiovascular Medicine ·Rainer Kaiser, Raphael Escaig, Johanna Erber, Leo Nicolai	49
14	Neurological implications of COVID-19-results of the LEOSS registry 2021 ·European Journal of Neurology ·Nina N. Kleineberg, Samuel Knauß, Eileen Gülke, Hans O. Pinnschmidt, Carolin Jakob, Jörg Janne Vehreschild, Paul Lingor, Kerstin Hellwig, Achim Berthele, (unknown), (unknown), Matthias Endres, Christian Gerloff, Christine Klein, Johanna Erber, Christiana Franke, Clemens Warnke	1
15	A Telemedicine-Guided Self-Collection Approach for PCR-Based SARS-CoV-2 Testing: Comparative Study 2021 ·JMIR Formative Research ·Silvia Würstle, Johanna Erber, (unknown), Dieter Hoffmann, Stanislas Werfel, (unknown), (unknown), Jochen Schneider, (unknown), M. Maier, (unknown), Roland M. Schmid, Ulrike Protzer, Michael Laxy, Christoph D. Spinner	2
16	A proof of concept study for the differentiation of SARS-CoV-2, hCoV-NL63, and IAV-H1N1 in vitro cultures using ion mobility spectrometry 2021 ·Scientific Reports ·Martin Feuerherd, (unknown), Johanna Erber, Jan Baumbach, Roland M. Schmid, Ulrike Protzer, Florian Voit, Christoph D. Spinner	7
17	Convalescent plasma therapy in B-cell-depleted and B-cell sufficient patients with life-threatening COVID-19 – A case series 2021 ·Transfusion and Apheresis Science ·Johanna Erber, (unknown), (unknown), Jochen Schneider, Hrvoje Mijočević, (unknown), Peter B. Luppa, Roland M. Schmid, Sebastian Rasch, Tobias Lahmer	5
18	Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report 2020 ·BMC Infectious Diseases ·Johanna Erber, (unknown), (unknown), Kathrin Rothe, Roland M. Schmid, Jochen Schneider, Christoph D. Spinner	13
19	AATF/Che-1—An RNA Binding Protein at the Nexus of DNA Damage Response and Ribosome Biogenesis 2020 ·Frontiers in Oncology ·Rainer Kaiser, Johanna Erber, Katja Höpker, Francesca Fabretti, Roman‐Ulrich Müller	9
20	Dual Inhibition of GLUT1 and the ATR/CHK1 Kinase Axis Displays Synergistic Cytotoxicity in KRAS -Mutant Cancer Cells 2019 ·Cancer Research ·Johanna Erber, (unknown), Jörg Isensee, (unknown), (unknown), Filippo Beleggia, Anna Schmitt, Rainer Kaiser, Florian Siedek, Thorsten Persigehl, Tim Hucho, Hans Christian Reinhardt	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact